News › Clinical Practice, Industry News, Patient Care

Efficacy and Safety of Kybella When Used Off-label

August 7, 2019

Calvin T. Sung, MD, et al, of the University of California, Riverside School of Medicine and University of California, Irvine, Department of Dermatology, performed a systematic literature search through PubMed, Cochrane, CINAHL and Web of Science databases, to investigate the safety and efficacy of injectable deoxycholic acid (DCA; Kybella; Allergan) when used off-label to treat fat tissue in areas of the body other than the submental region.
Read more at MedEsthetics >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Galderma to Acquire ZO Skin Health for $1.5 Billion
    • AscendPoint Agency Acquires Medical Marketing Whiz
    • PracticeQ Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Fresh Clinics Acquires Spakinect
    • Arkansas Nursing Board Comment Deadline Approaching for Medical Aesthetics and IV Hydration Guidance
Advertisement